Concepedia

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia

Paul N. Durrington, Mike Mackness, Deepak Bhatnagar, K. Julier, H. Prais, Sharon Arrol, J.G. Morgan, G.N.I. Wood

Atherosclerosis · 1998 · 149 citations · 37 references

DOI

Concepts

References

37

Measurement of protein using bicinchoninic acid

Pam Smith, Randall I. Krohn, Greg T. Hermanson et al. · Analytical Biochemistry · 1985 · 18.2K citations

, , +5

Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction

Lars Wilhelmsen, Kurt Svärdsudd, K Korsan-Bengtsen et al. · New England Journal of Medicine · 1984 · 1.7K citations

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Anders Hamsten, Göran Walldius, Alfred Szamosi et al. · The Lancet · 1987 · 1.5K citations

, , +7

Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein

Michael I. Mackness, Sharon Arrol, Paul N. Durrington · FEBS Letters · 1991 · 974 citations

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

M MACKNESS, Sharon Arrol, Caroline A. Abbott et al. · Atherosclerosis · 1993 · 813 citations

, , +11